Stockscreener 앱 받기
54.06
3.17%
1.66
시간 외 거래:
54.00
-0.06
-0.11%
전일 마감가:
$52.40
열려 있는:
$52.6
하루 거래량:
1.21M
Relative Volume:
1.00
시가총액:
$8.51B
수익:
$640.44M
순이익/손실:
$-743.28M
주가수익비율:
-
EPS:
-
순현금흐름:
$-206.93M
1주 성능:
-30.35%
1개월 성능:
+9.57%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$48.26
$54.31
1주일 범위
$48.26
$79.49
52주 변동 폭
$22.89
$79.49
Tempus Ai Inc Stock (TEM) Company Profile
명칭
Tempus Ai Inc
전화
800-976-5448
주소
600 WEST CHICAGO AVENUE, CHICAGO
TEM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
| VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
| HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-12 | 개시 | Piper Sandler | Neutral |
| 2024-07-09 | 개시 | BofA Securities | Buy |
| 2024-07-09 | 개시 | JP Morgan | Overweight |
| 2024-07-09 | 개시 | Longbow | Buy |
| 2024-07-09 | 개시 | Loop Capital | Buy |
| 2024-07-09 | 개시 | Morgan Stanley | Overweight |
| 2024-07-09 | 개시 | Needham | Buy |
| 2024-07-09 | 개시 | Stifel | Buy |
| 2024-07-09 | 개시 | TD Cowen | Buy |
| 2024-07-09 | 개시 | William Blair | Outperform |
모두보기
Tempus Ai Inc 주식(TEM)의 최신 뉴스
Short Interest in Tempus AI, Inc. (NASDAQ:TEM) Rises By 19.2% - MarketBeat
Tempus AI downgraded to hold by Stifel, valuation cited - MSN
Behind the Scenes of Tempus AI's Latest Options Trends - Benzinga
Sumitomo Mitsui Trust Group Inc. Buys 1,145,698 Shares of Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
AI Health Care Co. Can't Sink Ex-Worker's Sex Bias Claims - Law360
U.S. Indexes Dropped Thursday; Tempus AI Took Biggest Hit - Barron's
Sigma Planning Corp Acquires Shares of 23,369 Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Piper Sandler raises Tempus AI stock target by 75%, keeps Neutral rating after earnings - Investing.com
Tempus AI: Pioneering the Future of Precision Medicine Through AI-Driven Innovation (TEM) - Seeking Alpha
U.S. Indexes Declined Tuesday; Tempus AI Fell Furthest - Barron's
Tempus AI's (TEM) "Neutral" Rating Reaffirmed at Piper Sandler - MarketBeat
Tempus AI (NASDAQ:TEM) Sets New 12-Month HighHere's What Happened - MarketBeat
Tempus Partners with Flatiron Health, Brings Genomic Testing to 800+ Cancer Centers | TEM Stock News - StockTitan
Stifel cuts Tempus AI stock to Hold, lifts PT on Ambry Genetics deal - Investing.com Australia
Tempus AI stock receives notable PT boost from $40 to $70 at Piper Sandler - Investing.com India
Tempus AI (NASDAQ:TEM) Shares Gap DownHere's Why - MarketBeat
Tempus Study: Combined RNA-DNA Testing Boosts Lung Cancer Detection by 15.3% | TEM Stock News - StockTitan
Tempus AI (NASDAQ:TEM) Cut to "Hold" at Stifel Nicolaus - MarketBeat
Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates - MSN
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Tempus AI Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily
Tempus AI to Buy Ambry Genetics for $600M - Orange County Business Journal
Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting - 01Net
ARK Investment Management LLC Raises Holdings in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI Unveils Breakthrough Cancer Treatment Algorithm, Cost-Saving Study at SITC 2024 | TEM Stock News - StockTitan
Tempus AI Inc (NASDAQ:TEM) Continues Strong Growth with 33% Revenue Increase, Price Target Raised to $56 - Insider Monkey
Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test - 01Net
10 AI News You Shouldn’t Miss - Insider Monkey
Exciting Growth Potential Ahead for Tempus AI (TEM) - Insider Monkey
Tempus Launches Breakthrough Cancer Immunotherapy Test After Major Clinical Success | TEM Stock News - StockTitan
Tempus AI’s $600 Million Acquisition of Ambry Genetics - Global Legal Chronicle
Tempus AI to buy genetic testing company for $600M - MedTech Dive
Ambry Genetics Being Acquired by Tempus AI for $600M - Orange County Business Journal
Tempus AI (NASDAQ:TEM) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Needham raises Tempus AI stock target on Q3 results, acquisition By Investing.com - Investing.com Australia
Needham raises Tempus AI stock target on Q3 results, acquisition - Investing.com India
Tempus: Q3 Earnings Snapshot - The Advocate
Tempus AI Inc Reports 33% Revenue Growth to $180.9 Million in Q3 2024 Amid Strategic Acquisition - GuruFocus.com
Konica Minolta Sells Ambry Genetics to Tempus AI - TipRanks
Tempus AI Agrees to Acquire Ambry Genetics - MarketWatch
Tempus buying genetics lab company for $600 million - Crain's Chicago Business
Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics - Business Wire
Tempus to Report Third Quarter 2024 Financial Results on November 4 - 01Net
International Assets Investment Management LLC Buys 70,700 Shares of Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Cathie Wood's ARK offloads Palantir and Tesla stock, buys Tempus and Twist - Investing.com
Tempus AI Shows Improved Relative Price Performance; Still Shy Of Benchmark - MSN
Tempus Ai Inc (TEM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.46%
0.53%
자본화:
|
볼륨(24시간):